Share on Facebook
Share on Twitter
Share on LinkedIn
Share by Email
Print
FDA revoke Emergency Use Authorization for COVID-19 vaccine; New approval for treatment of iron deficiency in patients with heart failure; Lumryz now available for excessive daytime sleepiness; Vowst approved for C. difficile infection; Prevymis approved for prophylaxis of CMV disease in adult kidney transplant recipients.
Please login or register first to view this content.
